Organization Overview
Alternative names
abemaciclib (verzenio) (1 trial)
acalabrutinib (calquence) (1 trial)
atezolizumab (Tecentriq) (2 trials)
bevacizumab (avastin) (5 trials)
binimetinib (mektovi) (2 trials)
bortezomib (velcade) (1 trial)
brentuximab vedotin (adcetris) (2 trials)
cabozantinib (cometriq) (1 trial)
capecitabine (xeloda) (1 trial)
carboplatin (paraplatin) (1 trial)
carfilzomib (kyprolis) (1 trial)
cetuximab (erbitux) (2 trials)
cytarabine (cytosar-u) (1 trial)
dacarbazine (dtic-dome) (1 trial)
daratumumab (darzalex) (2 trials)
doxycycline (vibramycin) (1 trial)
durvalumab (imfinzi) (1 trial)
encorafenib (braftovi) (1 trial)
fluorouracil (efudex) (1 trial)
hyaluronidase (human recombinant) (Hylenex) (2 trials)
ibrutinib (imbruvica) (1 trial)
lenvatinib (lenvima) (2 trials)
multi-epitope folate receptor alpha peptide vaccine (1 trial)
palbociclib (ibrance) (1 trial)
palmitoylethanolamide (1 trial)
panitumumab (vectibix) (2 trials)
pazopanib (votrient) (1 trial)
pembrolizumab (keytruda) (2 trials)
pemigatinib (Pemazyre) (2 trials)
pertuzumab (perjeta) (1 trial)
polatuzumab vedotin (Polivy) (1 trial)
pomalidomide (pomalyst) (1 trial)
prednisone (meticorten) (1 trial)
ramucirumab (cyramza) (1 trial)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Follicular (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Breast Carcinoma In Situ (Phase 3)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Ductal (Phase 2)
Carcinoma, Ductal, Breast (Phase 3)
Carcinoma in Situ (Phase 3)
Carcinoma, Intraductal, Noninfiltrating (Phase 3)
Carcinoma, Islet Cell (Phase 2)
Carcinoma, Lobular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Papillary (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cholangiocarcinoma (Phase 1)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 2)
Coronavirus Infections (Phase 2)
Disease Progression (Phase 2)
Embolism (Phase 3)
Esophageal Neoplasms (Phase 2)
Fanconi Anemia (Phase 2)
Gastrinoma (Phase 2)
Glucagonoma (Phase 2)
Hodgkin Disease (Phase 2)
Hot Flashes (Phase 3)
Infections (Phase 2)
Insulinoma (Phase 2)
Laboratory Infection (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Melanoma (Phase 2)
Multiple Myeloma (Phase 2)
Neoplasms (Phase 3)
Neoplasms, Plasma Cell (Phase 2)
Neuroendocrine Tumors (Phase 2)
Pancreatic Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 3)
Pulmonary Embolism (Phase 3)
Rectal Neoplasms (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Somatostatinoma (Phase 2)
Stomach Neoplasms (Phase 2)
Thromboembolism (Phase 3)
Thrombosis (Phase 3)
Thyroid Cancer, Papillary (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Unilateral Breast Neoplasms (Phase 2)
Venous Thromboembolism (Phase 3)
Venous Thrombosis (Phase 3)
Waldenstrom Macroglobulinemia (Phase 2)
